BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$672M |
| 2 |
Microsoft
MSFT
|
+$541M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$441M |
| 4 |
Pfizer
PFE
|
+$425M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$805M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$535M |
| 3 |
Lam Research
LRCX
|
+$482M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$359M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.25% |
| 2 | Financials | 7.39% |
| 3 | Consumer Discretionary | 7.31% |
| 4 | Healthcare | 6.72% |
| 5 | Communication Services | 5.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZYXI
2926
DELISTED
Zynex
ZYXI
| $312K | ﹤0.01% |
38,255
-4,084
| -10% | -$34.4K |
|
2927
Ocular Therapeutix
OCUL
$2.25B
| $311K | ﹤0.01% |
35,801
-19,513
| -35% | -$161K |
|
2928
Scholastic
SCHL
$784M
| $311K | ﹤0.01% |
9,711
+4,845
| +100% | +$155K |
|
2929
Nektar Therapeutics
NKTR
$2.57B
| $311K | ﹤0.01% |
15,923
+15,118
| +1,878% | +$288K |
|
|
VRE
2930
DELISTED
Veris Residential
VRE
| $310K | ﹤0.01% |
17,338
-90
| -0.5% | -$1.48K |
|
2931
PUT
CarMax
KMX
$8.33B
| $310K | ﹤0.01% |
+40
| New | +$3.16K |
|
2932
XBiotech
XBIT
$75M
| $310K | ﹤0.01% |
40,040
+25,987
| +185% | +$171K |
|
2933
PENN Entertainment
PENN
$2.57B
| $309K | ﹤0.01% |
16,407
-116,414
| -88% | -$2.22M |
|
2934
Aviat Networks
AVNW
$282M
| $308K | ﹤0.01% |
14,244
+12,306
| +635% | +$328K |
|
2935
Domo
DOMO
$184M
| $308K | ﹤0.01% |
40,991
+2,091
| +5% | +$16K |
|
2936
Vishay Precision Group
VPG
$908M
| $307K | ﹤0.01% |
11,863
+7,432
| +168% | +$211K |
|
2937
The RMR Group
RMR
$337M
| $307K | ﹤0.01% |
12,100
+5,294
| +78% | +$131K |
|
2938
Aehr Test Systems
AEHR
$4.02B
| $305K | ﹤0.01% |
23,709
+11,172
| +89% | +$162K |
|
2939
Vanguard Morningstar Large-Cap ETF
VV
$54.9B
| $304K | ﹤0.01% |
1,156
-1,215
| -51% | -$308K |
|
2940
Preformed Line Products
PLPC
$2.29B
| $304K | ﹤0.01% |
2,371
+274
| +13% | +$33.3K |
|
2941
8x8 Inc
EGHT
$290M
| $302K | ﹤0.01% |
148,201
+11,287
| +8% | +$24.9K |
|
|
DHIL
2942
DELISTED
Diamond Hill
DHIL
| $301K | ﹤0.01% |
1,864
-429
| -19% | -$66K |
|
2943
DNOW Inc
DNOW
$3.04B
| $301K | ﹤0.01% |
23,286
-14,457
| -38% | -$191K |
|
|
NPKI
2944
NPK International
NPKI
$1.19B
| $299K | ﹤0.01% |
43,138
+36,286
| +530% | +$279K |
|
2945
Star Bulk Carriers
SBLK
$3.11B
| $299K | ﹤0.01% |
12,614
-238,502
| -95% | -$5.29M |
|
2946
Kura Oncology
KURA
$882M
| $299K | ﹤0.01% |
15,287
+11,158
| +270% | +$226K |
|
2947
MacroGenics
MGNX
$259M
| $299K | ﹤0.01% |
90,779
+71,643
| +374% | +$279K |
|
2948
Mistras Group
MG
$556M
| $297K | ﹤0.01% |
26,165
+21,919
| +516% | +$225K |
|
|
SEI
2949
Solaris Energy Infrastructure
SEI
$3.94B
| $297K | ﹤0.01% |
23,300
+7,090
| +44% | +$84.4K |
|
2950
W&T Offshore
WTI
$546M
| $297K | ﹤0.01% |
138,029
+104,156
| +307% | +$232K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2024 Portfolio in Review
As of Q3 2024, BNP Paribas Financial Markets held 4,296 positions worth $149B, up 21% from $123B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets's Q3 2024 filing shows 266 new, 2,153 increased, 1,264 reduced and 157 closed positions. Its largest new stake was Ferguson: 319,382 shares worth $63.4M. The largest sale was Visa, an estimated $805M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q3 2024 buy was Ferguson: 319,382 shares worth $63.4M.
- BNP Paribas Financial Markets added most to NVIDIA in Q3 2024, an estimated $672M increase.
- BNP Paribas Financial Markets's biggest Q3 2024 reduction was Visa, cutting an estimated $805M.
- BNP Paribas Financial Markets fully exited Lam Research in Q3 2024, selling an estimated $482M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $149B portfolio in Q3 2024.
- BNP Paribas Financial Markets opened 266 new positions and closed 157 in Q3 2024.
- BNP Paribas Financial Markets's portfolio value rose 21% quarter-over-quarter to $149B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2024, filed 13 Nov 2024.